News
-
-
PRESS RELEASE
MIRA Pharmaceuticals Reports No Brain Toxicity in FDA-Required Study of Ketamir-2, Confirming Absence of Ketamine-Linked Neurotoxicity
MIRA Pharmaceuticals announces positive preclinical results for oral NMDA receptor antagonist Ketamir-2, showing no brain toxicity. Phase I clinical trial ongoing -
-
PRESS RELEASE
E-Cite Motors to Expand U.S. Manufacturing and Increase Domestic Component Sourcing Amid Favorable Economic Conditions and Rising Tariffs
E-Cite expands US production of key vehicle components for RJ, RT, and GT models in response to tariffs and economic trends, emphasizing American innovation and market growth -
-
-
-
PRESS RELEASE
Lahontan Submits Notice of Intent for Additional Drilling at Santa Fe
Lahontan Gold Corp. plans additional exploration and drilling at Santa Fe Mine project in Nevada's Walker Lane gold belt. Company awaiting approval from BLM for the amended Notice of Intent. CEO Kimberly Ann expresses enthusiasm for the upcoming drill program -
-